SEC Form 6-K filed by Theratechnologies Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2025.
Commission File Number 001-35203
Theratechnologies Inc.
(Translation of registrant’s name into English)
2015 Peel Street, Suite 1100
Montreal, Quebec
H3A 1T8, Canada
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
☒ Form 20-F ☐ Form 40-F
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| THERATECHNOLOGIES INC. | ||
| By: | /s/ Philippe Dubuc | |
| Name: | Philippe Dubuc | |
| Title: | Senior Vice President and Chief Financial Officer | |
Date: April 9, 2025